Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Collier

Showing results (321-330 of 508) with videos related to

Pageof 51
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complexA C Collier, R W Coombs, D Katzenstein, et al.
Mitochondrial DNA. Part B, Resources|January 23, 2023
Complete mitogenome sequence of <i>Aedes (Hulecoeteomyia) japonicus japonicus</i> from Hawai'i IslandSangwoo Seok, Christopher M Jacobsen, Ana L Romero-Weaver, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
Annals of Clinical and Translational Neurology|July 4, 2020
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIVRonald J Ellis, Monica Diaz, Ned Sacktor, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
Insects|December 23, 2020
Evidence for Divergent Selection on Immune Genes between the African Malaria Vectors, <i>Anopheles coluzzii</i> and <i>A. gambiae</i>Yoosook Lee, Lattha Souvannaseng, Travis C Collier, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Central nervous system manifestations in human immunodeficiency virus infection without AIDSA C Collier, C Marra, R W Coombs, et al.
Pageof 51

Showing results (321-330 of 508) with videos related to

Sort By:
Pageof 51
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|October 1, 1995
Safety, pharmacokinetics, and antiviral response of CD4-immunoglobulin G by intravenous bolus in AIDS and AIDS-related complexA C Collier, R W Coombs, D Katzenstein, et al.
Mitochondrial DNA. Part B, Resources|January 23, 2023
Complete mitogenome sequence of <i>Aedes (Hulecoeteomyia) japonicus japonicus</i> from Hawai'i IslandSangwoo Seok, Christopher M Jacobsen, Ana L Romero-Weaver, et al.
The New England Journal of Medicine|October 11, 1990
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials GroupM A Fischl, C B Parker, C Pettinelli, et al.
JAMA|January 14, 2000
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimensD V Havlir, N S Hellmann, C J Petropoulos, et al.
Annals of Clinical and Translational Neurology|July 4, 2020
Predictors of worsening neuropathy and neuropathic pain after 12 years in people with HIVRonald J Ellis, Monica Diaz, Ned Sacktor, et al.
HIV Clinical Trials|December 17, 2013
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202Philip M Grant, Camlin Tierney, Chakra Budhathoki, et al.
Insects|December 23, 2020
Evidence for Divergent Selection on Immune Genes between the African Malaria Vectors, <i>Anopheles coluzzii</i> and <i>A. gambiae</i>Yoosook Lee, Lattha Souvannaseng, Travis C Collier, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Central nervous system manifestations in human immunodeficiency virus infection without AIDSA C Collier, C Marra, R W Coombs, et al.
Pageof 51